Submandibular Gland Stem Cell Transplantation

This study is a phase I safety and feasibility study to treat head and neck cancer patients with autologous salivary gland stem cell transplantation after postoperative (chemo)radiotherapy.

Trial Details

NCT ID
NCT04593589
Phase
PHASE1
Sponsor
University Medical Center Groningen
Status
RECRUITING
Cancer Type
Salivary Gland Head and Neck Cancer
Interventions
  • Submandibular Gland Stem Cell Transplantation
Locations (sample)
  • Groningen, Netherlands|53.21917,6.56667

Key Eligibility Criteria

  • Squamous cell carcinoma (SCC) originating from the mucosa of the oral cavity;
  • Primary resection of tumour including an electively or therapeutic ipsilateral neck dissection (at least levels Ib to III, including the submandibu…
  • Postoperative radiotherapy or chemoradiation, including prophylactic or therapeutic irradiation of the contralateral side of the neck (where the re…
  • Age ≥ 18 years;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Salivary Gland Head and Neck Cancer Trials on Trialify →